88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

LOTTE Biologics Completes Construction of Songdo Bio Campus Plant 1 and Obtains Approval for Use INCHEON, South Korea and SAN DIEGO , June 22, 2026 /PRNewswire/ -- LOTTE Biologics announced that it has completed major construction and obtained approval for use for Plant 1 at its Songdo Bio ... 2026-06-22T Biotechnology Construction/Building Health Care/Hospital
Statement on Novogene Erroneously Listed on 1260H List BEIJING , June 20, 2026 /PRNewswire/ -- On June 8, 2026, the U.S. Department of Defense (DOD) erroneously designated Novogene Co., Ltd. on its Section 1260H list under the National Defense Authorization ... 2026-06-20T Biotechnology Health Care/Hospital
Seoul National University Hospital to Expand Global K-Bio Collaboration at BIO USA 2026 SAN DIEGO and SEOUL, South Korea , June 19, 2026 /PRNewswire/ -- Seoul National University Hospital (SNUH) will take a major step toward expanding K-Bio's global presence and international collaboration ... 2026-06-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals Trade show news
WuXi Biologics' Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market SUZHOU, China , June 18, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its Biosafety Testing Center ... 2026-06-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration with Hygtia Therapeutics CAMBRIDGE, Mass. and HONG KONG , June 17, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence ... 2026-06-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat STOCKHOLM , June 17, 2026 /PRNewswire/ -- Gesynta Pharma AB, a Swedish clinical stage pharmaceutical company focusing on chronic inflammatory diseases, today announced that 50% of the target of 190 ... 2026-06-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ligufalimab (CD47)-Based Combination Achieves Deep Responses and Survival Benefit in Frontline AML: Phase II Results Presented in Oral Session at EHA 2026 HONG KONG , June 17, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind, placebo-controlled ... 2026-06-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Dioseve Secures JPY 1.45 Billion to Advance iPS Cell‑Based IVF Support, Adds TIME100 Scientist as Advisor Funding round and NEDO Deep Tech Startup Support Program selection will support development and clinical adoption of DIOS ‑ 101, an iPS cell ‑ derived co ‑ culture designed to reduce the burden of ... 2026-06-17T Biotechnology Health Care/Hospital
Ruixiang Silicone Releases Platinum-Cured Medical Silicone Tubing for Cardiac, Infusion, and Hemodialysis Device Manufacturers USP Class VI, ISO 10993 biocompatibility evaluation, and ISO 13485:2016 quality system certification, manufactured at an FDA-registered facility ... 2026-06-16T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Angel Yeast Chairman Reflects on 40 Years of Bringing Yeast to Millions of Households Worldwide Exclusive interview highlights advances in yeast protein and yeast extracts, global expansion, sustainability, and future growth drivers ... 2026-06-16T Biotechnology Food/Beverages Health Care/Hospital

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved